The ADP-ribosylation factor 1 (ARF1) has been reported as significantly elevated in various cancers [41], and its expression in prostate cancer correlated with activation of ERK1 and ERK2, leading to cell proliferation [42]. This evidence concerns the gene ARF1 and prostate carcinoma.